Ultrasound biopsy accuracy for breast cancer lymph node spread
Part of Cancer, Skin clinical trials.
This study tests how well ultrasound-guided needle biopsies can detect whether cancer has spread to lymph nodes under the arm in people with breast cancer. The results help doctors understand if this imaging method is reliable for treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old
- You have been diagnosed with primary breast cancer (confirmed by tissue sample)
- You have had an ultrasound exam to check your underarm lymph nodes
- You have not received chemotherapy or radiation before surgery
- Your lymph node status must be confirmed by pathology (tissue examination) within 6 weeks of your ultrasound
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses ultrasound to examine arm tissue in women who have had breast cancer. It aims to see if ultrasound can reliably detect changes in arm soft tissue, which may help identify or prevent arm swelling and stiffness after treatment.
This study uses multiple ultrasound methods to check the lymph nodes under the arm in people newly diagnosed with breast cancer. It aims to better understand the spread of cancer before surgery.
This trial compares two techniques for finding the first lymph node that breast cancer might spread to (the sentinel node). It tests if using ultrasound guidance through a small axillary incision is better than the standard method.
This early-phase study tests a 3D ultrasound scan to see lymph nodes in people being evaluated for breast cancer. It may help doctors better image lymph nodes during routine care.
This study uses ultrasound imaging to monitor how lymph nodes in the armpit respond to chemotherapy before surgery. The goal is to predict which patients will have a good response to treatment and may need less extensive surgery.
This study looks at whether substances called metabolites in your blood and breast tissue can help predict if breast cancer has spread to the first lymph node (sentinel node). If you are scheduled for breast cancer surgery and have not had prior treatment, the study team will use your blood and tissue samples to try to improve prediction.
Hear when a new Lymphatic Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.